Ting Xu

机构：China Jiliang University · ORCID：0000-0001-7827-4421

发表论文 41 篇 · 总被引 361 次 · h-index 12

代表论文

• KN046, a bispecific antibody against PD-L1 and CTLA-4, plus chemotherapy as first-line treatment for metastatic NSCLC: A multicenter phase 2 trial (2024 · Cell Reports Medicine · 被引 44)
• Unraveling the complex pathophysiology of white matter hemorrhage in intracerebral stroke: A single‐cell RNA sequencing approach (2024 · CNS Neuroscience & Therapeutics · 被引 30)
• Metagenomic and metaproteomic analyses of microbial amino acid metabolism during Cantonese soy sauce fermentation (2023 · Frontiers in Nutrition · 被引 19)
• Advancements in AI for Oncology: Developing an Enhanced YOLOv5-based Cancer Cell Detection System (2024 · International Journal of Innovative Research in Computer Science & Technology · 被引 18)
• Distinct Thalamo‐Subcortical Circuits Underlie Painful Behavior and Depression‐Like Behavior Following Nerve Injury (2024 · Advanced Science · 被引 16)
• Emerging Neuroprotective Strategies: Unraveling the Potential of HDAC Inhibitors in Traumatic Brain Injury Management (2024 · Current Neuropharmacology · 被引 15)